Back to top
more

Cardinal Health (CAH)

(Delayed Data from NYSE)

$93.74 USD

93.74
2,250,237

-0.36 (-0.38%)

Updated Jul 15, 2024 04:00 PM ET

After-Market: $93.76 +0.02 (0.02%) 4:32 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Cardinal Health, Inc. (CAH) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Cardinal (CAH). This makes it worthwhile to examine what the stock has in store.

DexCom (DXCM) Announces Solid Preliminary Q4 Revenues

DexCom's (DXCM) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its CGM sales.

Here's Why You Should Retain Veradigm (MDRX) Stock for Now

Investors continue to be optimistic about Veradigm (MDRX) owing to its strategic alliances.

Are Investors Undervaluing Cardinal Health (CAH) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Cardinal Health (CAH) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Cardinal Health (CAH) closed at $77.57, marking a -1.36% move from the previous day.

The Zacks Analyst Blog Highlights Cardinal Health, Conagra Brands, Ingredion, Atmos Energy and NRG Energy

Cardinal Health, Conagra Brands, Ingredion, Atmos Energy and NRG Energy are included in this Analyst Blog.

Here's Why You Should Retain QuidelOrtho (QDEL) Stock for Now

Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.

QuidelOrtho (QDEL) Reports Solid Preliminary Q4 Revenues

QuidelOrtho's (QDEL) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its non-COVID-19 product sales.

Baxter (BAX) Plans to Form Standalone Kidney Care Company

Baxter (BAX) plans several strategic actions, including spin-off of Renal Care and Acute Therapies global business units into an independent, publicly traded company to simplify its operating model.

Ethan Feller headshot

2 Dividend Aristocrat Stocks to Buy and Never Sell

Dividend Aristocrats are steady and maybe a bit boring. But that can be a good thing, especially during periods of volatility

Looking for a Growth Stock? 3 Reasons Why Cardinal (CAH) is a Solid Choice

Cardinal (CAH) could produce exceptional returns because of its solid growth attributes.

Here's Why You Should Buy Cardinal Health (CAH) Stock Now

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, the cost of products continues to rise.

AngioDynamics (ANGO) Q2 Earnings, Revenues Top Estimates

AngioDynamics (ANGO) registers strong revenue growth in the Med Tech and Med Device businesses in second-quarter fiscal 2023.

Tirthankar Chakraborty headshot

5 Top Recession-Proof Dividend Stocks to Buy in 2023

Investors should place their bets now on dividend-paying recession-proof stocks such as Cardinal Health (CAH), Conagra Brands (CAG), Ingredion (INGR), Atmos Energy (ATO) and NRG Energy (NRG) for a steady income.

3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio (Revised)

Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.

Here's Why You Should Retain Stryker (SYK) Stock for Now

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on it.

3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio

Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.

Here's Why You Should Retain PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) continues to gain from a solid product portfolio despite forex woes.

Sweta Killa headshot

5 Stocks in S&P 500 ETF With 40% Gains in 2022

The S&P 500 wrapped up its worst year since 2008, tumbling 20%. Persistently high inflation, a hawkish Fed, Russia's invasion of Ukraine and a resurgence of COVID-19 cases in China weighed heavily on investor sentiment.

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?

Style Box ETF report for DEF

Is Invesco Defensive Equity ETF (DEF) a Strong ETF Right Now?

Smart Beta ETF report for DEF

Are Medical Stocks Lagging Acer Therapeutics (ACER) This Year?

Here is how Acer Therapeutics Inc. (ACER) and Cardinal Health (CAH) have performed compared to their sector so far this year.

Zacks.com featured highlights include Archer-Daniels-Midland, Cardinal Health, Insperity, Deere & Co. and H&R Block

Archer-Daniels-Midland, Cardinal Health, Insperity, Deere & Co. and H&R Block are part of the Zacks Screen of the Week.

What Makes Cardinal Health (CAH) a Strong Momentum Stock: Buy Now?

Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.